bioSyntagma Company
bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.
Technology:
Biotechnology, Life Science
Industry:
Clinical Development, Data Processing
Headquarters:
Phoenix, Arizona, United States
Founded Date:
2015-04-02
Employees Number:
1-10
Investors Number:
2
Total Funding:
1382086
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-03-19
Last Funding Type:
Grant
Register and Claim Ownership